Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the United States.
Related Posts
Bristol Myers Squibb plans $2 billion in cost cuts by 2027, issues weak guidance
The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face competition from cheaper generics.
Judge rejects Trump request to delay sentencing in New York hush money case
A New York judge last week rejected a request by President-elect Trump to dismiss a case where he was found guilty of falsifying business records.
China’s DeepSeek quietly releases upgraded R1 AI model, ramping up competition with OpenAI
DeepSeek rose to prominence this year after its free, open-source R1 reasoning model outperformed offerings from rivals including Meta and OpenAI.